Andere Kunden interessierten sich auch für
![Endosymbiotic Archaea e Digoxin Syndromes]( "Endosymbiotic Archaea e Digoxin Syndromes")
Endosymbiotic Archaea e Digoxin Syndromes36,99 €![Endosymbiotic Archaea and Mucopolysaccharidosis Syndrome]( "Endosymbiotic Archaea and Mucopolysaccharidosis Syndrome")
Endosymbiotic Archaea and Mucopolysaccharidosis Syndrome36,99 €![Endosymbiotic Archaea and Cholesterol Depletion Syndrome]( "Endosymbiotic Archaea and Cholesterol Depletion Syndrome")
Endosymbiotic Archaea and Cholesterol Depletion Syndrome36,99 €![Endosymbiotic Archaea and Selenium Deficiency Syndrome]( "Endosymbiotic Archaea and Selenium Deficiency Syndrome")
Endosymbiotic Archaea and Selenium Deficiency Syndrome36,99 €![Endosymbiotic Archaea and Mitochondrial Disease]( "Endosymbiotic Archaea and Mitochondrial Disease")
Endosymbiotic Archaea and Mitochondrial Disease36,99 €![Symbiotic Metabolonomics - Endosymbiotic Archaea and Porphyria]( "Symbiotic Metabolonomics - Endosymbiotic Archaea and Porphyria")
Symbiotic Metabolonomics - Endosymbiotic Archaea and Porphyria46,99 €![Endosymbiotic Archaea and Hyperammonemic Syndrome]( "Endosymbiotic Archaea and Hyperammonemic Syndrome")
Endosymbiotic Archaea and Hyperammonemic Syndrome36,99 €
The climate change results in endosymbiotic actinidic archaeal growth in the human system and cholesterol catabolism resulting in endogenous digoxin synthesis. The endosymbiotic archaea catabolize cholesterol for its energetics and synthesizes digoxin. Digoxin functions as an endogenous sodium potassium ATPase inhibitor and neuro-immuno-endocrine integrator. The increased endosymbiotic archaeal growth and resultant endogenous digoxin synthesis in relation to climate change results in neanderthalisation of homo sapiens and human disease. Digoxin can inhibit reverse transcriptase activity and RNA editing resulting in suppression of endogenous retroviral growth. This produces inhibition of HERV expression and jumping gene phenomena producing in adynamicity of the human genome. The digoxin interference with HERV expression and RNA editing and resultant inhibition of genomic, metabolic, neural and immune diversity produces autoimmune disease, cancer, metabolic syndrome, degenerations,schizophrenia and autism. A new endosymbiotic archaea related hypodigoxinemic and hyperdigoxinemic syndrome is described.